pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-758 |
Genomic Coordinates | chr14: 101026020 - 101026107 |
Synonyms | MIRN758, hsa-mir-758, MIR758 |
Description | Homo sapiens miR-758 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-758-5p | |||||||||||||||||||||||||||||||||||||||||||||
Sequence | 15| GAUGGUUGACCAGAGAGCACAC |36 | |||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||
Experiments | SOLiD | |||||||||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ELL2 | ||||||||||||||||||||
Synonyms | MRCCAT1 | ||||||||||||||||||||
Description | elongation factor for RNA polymerase II 2 | ||||||||||||||||||||
Transcript | NM_012081 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ELL2 | |||||||||||||||||||||
3'UTR of ELL2 (miRNA target sites are highlighted) |
>ELL2|NM_012081|3'UTR 1 AACTCTGCTTGGACCAGAAGATGTGAATAAACTTAAGCTTATTTATTTAAAATTCCAAATGAGTTGCTCTAGATTCTAAA 81 AAGGTGAAACTTTGGCTGTTGAAAGTTTCAGTATTAGTAAACTTGAGTTACTTTTTCTTTTCCATTTTACTTTGCTTCCC 161 TGCATTTCGAAGCTGCTCTTTCTGGTCCTCCCCACCACCCCACCCCCAAGACTTGTGTTTGTTAATAGAAATAATTTTTT 241 TAGGTATTGGGGATCCATTGTCTATATTTCAAATCAGTTTTTTTTCCTCAAAAACTTGTGTTTGTTATTAGAAATGATTT 321 TTTAGATATTGGGGATCCAGTGTCCACACTTAAAAGTTGTATGTGTTTAAAAAACAACAACAGTAATGTGCAAGGTGAAA 401 TGCTTTTGGATAAACGTAAGCCTATTTTCTGACGTTTCTTAATGCAAACTCTTTGCCTTAAATGGTAGAATATTTAGAAA 481 TTTGCACAAAATTAAAAAAATAAACATTGTCTTGGAGGGTTAAAAAATAGAAAGGTGTATGTGTATAGATTCACATACAC 561 ATATGTATATACAGGCTGACTTGATCTAGAACATTAAATCCGCCCTGCAAGTTAACCCCCCATTGCAATGGTTGCCTTAA 641 GGTGTTTGCTAGTTGTGTACATAGTGTGGTTAATCATTAGCTACACTGCTTCCCACTTGATTAGAGCAATGGGAAGCATA 721 CTGTGGCCTACCAGCATCTGGAAGTGTGTGCTCGATCTGTATGTGTGCAGAGGTGGTGTGGATGTGAGCGTGCATGAAGG 801 AAAAAAAGCTGCTACTCCTAGTAGGCCAAACGCTCAGGTTAAACAACTGACGAGTGTTACTGTAGGGTGTTTTTTTGTTT 881 TTTTGTTTTTTTTCTTCTATCAAATTGCTACTTTTGTTGTGGAAGACAAAAGCATTTCCATTTCAACGAGTTTGTCAGCT 961 TTATTAATGTTGGGCAAAAATTGATATGTCATGAAAATGAAACAGATCTATAGTTTTGGGACAAAATTATAAAATGAAAT 1041 GTGTAGGTAACCTATTTATATACTGCTATAAAGTATTTTTTGAAGAGAGATATGCAAAGAAGCTATTACCTACATAAGAG 1121 GTATATTTAAAGATTTTTTTTTTCATCCTGGTGCCAGGAATATAAAAAAGAGTGGATATATTTAACCATAACATACTGTG 1201 ATTCATCAAACAGCACAAACTTTCATTTCATGGAGTTTATCTGTTGACATTGATTTAAACTGTCACTTGTTTTATCATGT 1281 GGGAACATAAGTTATGTGGTCAAAAATATAAGGATTTTGAATTAATGTTGATTCAAGTTGTATTGTCTTATTGTATTGTC 1361 TTTTCAAAGTGCTGCCAGTTGAAAAGGGAAGCATTATGTTTACAAATCTGTTTTGAAATGTTTGCCAAAATTTTGGTAGT 1441 GTCTTTAATAAAGATGTTTGTCTCCAGCATCCAGAAAAATAAATGAATAACTTTGTTGTGTATCACTGTAAACCAGAAAA 1521 ATGTTGGTTATCTAGAAAACTTGAGAGAGCATGTAGATTAACTTTTCTCTTTGGAGTTCTAAAACATTAACTGGAAAGAT 1601 TAGATAATATACTAAATGTATACAGAAGTATACAGACTATACAAAGACTGAAACAAGTCCCTTTTGCACTACAACTCTAT 1681 AACATTACCGCAGAAATTTTGGTTCTATGTAGCATGGACCTCCTAAGGAATTCTGTTTCTTTTAGCATTGAGATCCCTGG 1761 TGCTCTTTTTTTACCTCAGAATTGGTACAATCATTATTAAACGTTAATTTATTTCAAACTTTTTAATTGAAAAAAGGAAA 1841 GGGAAACTTAATTGGGGATAAATTCAGGCATCATATTATTATGATAGAGTCTCCTGAGTGGTTCGTCTATAGGTAATGAA 1921 CTCATTGGTGTTATTTCTTGGACATCTTGGCCTTTTAATCAAAGACTGTGTGCTGCTATTTGCTATGAGCAAGGTTTCTC 2001 AAAAGCAAAAGGTGCTTGGACCATTTGGATCACCTGAGTTAGAATCTCTAGGTATAGGGCCCAAGTATCTGCATTTTCAC 2081 AGGTTTCTTGTAGGTGACTTTCTGCAAGCTAAAGTATGAGAACCATTGGCTTGGATGTAGTTCTAAACTTTTAGGTCTGT 2161 AAATCTTGAAATCTTGAACTGAAGGTCAACTATTGGCTTTTTTTTTTTTTTAATGTCCATCATGTCAGCAGGTGCAAATC 2241 ACTTTTCCCCTTTGCATGATCTGAGGCACCTCCTCAGTTGTTTCACTGCCAACTCTTGTTTCAGAACCTGTTTACAAACA 2321 AGCCTTCCAGTTGGTGAATGGTTAGCCATTGGAGCTCCTACCCTGTACATCAGCACATCTTCTGGTTTACAAGTTGGGTA 2401 ACAATGAAAGCTGGAGATGCTAAATGGAAATCCAGCATTGCATACCCTTAGACCTGATCACATACCAGTAAAAGCCTTAA 2481 TTTAGATGTTAGTTGTATGTGTTGGACAGATCCTTGCAAAAGTGTGTCTGTCTATTAGTTGTAAATTTGAAAATTATAAA 2561 TCTCTGAATCTGCTACTATCCAAGTTTCATCCCTTTTGAAGATGAGGCATGAGCCTATTAAAATATTTATAATCATTTTT 2641 CGTCCCCTACTGCAAGACTTTTAGATTCTTACAAATGATTACTACAGGAATAGTGGCCACTTAATGTCAGTTACTCCGGT 2721 GGAAGAATTTATCTAGTTTTTTTTCTTTTCTTTTTTGGAAGGATGGTGTGAAAAATAGCAAGATTAGAGAATGAGTTGTA 2801 TAGTTTTTTCTATCACATTTCATCTAAAATGATTTGAAGGACTTTTGAAGATTTTTACCAACATCCTTAAATCAACTCCA 2881 GGTTGGATGAACAACTGATTTAAAACAAACTAAGAGAACATTAACTAGATGTGGGCTTTTTAAAATATATAGGTATTGCA 2961 TTTCCTACCTTGTTATTTATTCCACTTTGAATACTTTAGAGGGCTTAACTTTCAACTCTTTAAGGTAGTAATGGATAGTT 3041 TTATACTTGTTCTCACAAAATTGTTATGGTCAGTTTATATCATTGCTCCATGCATTGATTATAAAAATTCAGTATTAATT 3121 TTTTCTGATCTTATAAGCTTTATAGGAGTTTTCTTTTCTCTTATAAAGTGTTTCACCTTATGTAAAACAAATGCCTGCTT 3201 GCATATTGGAAGATGTTGAAATTAGTTTTAGACAAAAGTGGTCCATCAATTCAGACACTCTGCTTGGATGCCTTACCCTT 3281 TTCATTAGTGCATTCTTTGCTTCTGAAACTTGGCAGAAACTCGTTAGCCAGTCCACTGCCTTTCTGACAATGTGTGGAGT 3361 CACGTATGCTTGGTATATGCCTTTACTACTTTTAAAGTTCTACAGTTTATTACTTGCCCAAGTGTTACTAAATCCTTTTC 3441 TTATGTGTACTGGATGGAGAAAAAATTATAGCCAGCACTTTGAGAGGAAAGTTTTCAGAAACAATATTAACTGGCACTAC 3521 TAACTGAAGGCCACAGGAGATGCTATCAATGTTATTTGTAATCTGAAGATTGAACAAGGCTGTGAGGCTCATTTCAAACT 3601 ATTTTGAGGTGTTAAAATATATATATGCTGTTTCTCAGCTGTTCCACTCAAACCGTGTTAGGACTCTCAAAGGTAAAATG 3681 TCACAGGGGCTTTTCAGTTGTTACAGAGCTCAGCAGCTGTGGTTGCCCCTGTTCTACACCAATTTCAGTTCAATAAAAAT 3761 GTTAACTTTGCAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | C8166 , TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000237853.4 | 3UTR | AUAUUUAACCAUAACAUACUGUGAUUCAUCAAACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000237853.4 | 3UTR | AUAUAUUUAACCAUAACAUACUGUGAUUCAUCAAACAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
62 hsa-miR-758-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT085323 | MORC3 | MORC family CW-type zinc finger 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT089441 | STAMBP | STAM binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT089456 | TET3 | tet methylcytosine dioxygenase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT111856 | CCND1 | cyclin D1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT184933 | ZNF268 | zinc finger protein 268 | ![]() |
![]() |
2 | 2 | ||||||
MIRT215288 | CREBRF | CREB3 regulatory factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT237300 | LPP | LIM domain containing preferred translocation partner in lipoma | ![]() |
![]() |
2 | 2 | ||||||
MIRT238446 | MYO10 | myosin X | ![]() |
![]() |
2 | 4 | ||||||
MIRT273827 | RPL41 | ribosomal protein L41 | ![]() |
![]() |
2 | 2 | ||||||
MIRT282703 | HOOK1 | hook microtubule tethering protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT347970 | ZNF850 | zinc finger protein 850 | ![]() |
![]() |
2 | 2 | ||||||
MIRT371076 | KLF3 | Kruppel like factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464339 | USP6NL | USP6 N-terminal like | ![]() |
![]() |
2 | 2 | ||||||
MIRT470034 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT477506 | ELL2 | elongation factor for RNA polymerase II 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT482886 | CACNA2D3 | calcium voltage-gated channel auxiliary subunit alpha2delta 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492606 | POLR3E | RNA polymerase III subunit E | ![]() |
![]() |
2 | 2 | ||||||
MIRT502294 | GNG12 | G protein subunit gamma 12 | ![]() |
![]() |
2 | 6 | ||||||
MIRT507600 | DCTN4 | dynactin subunit 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT510728 | SON | SON DNA binding protein | ![]() |
![]() |
2 | 6 | ||||||
MIRT514065 | KCNJ6 | potassium voltage-gated channel subfamily J member 6 | ![]() |
![]() |
2 | 8 | ||||||
MIRT519718 | ZNF512B | zinc finger protein 512B | ![]() |
![]() |
2 | 4 | ||||||
MIRT520890 | STRN | striatin | ![]() |
![]() |
2 | 2 | ||||||
MIRT521760 | PPIL1 | peptidylprolyl isomerase like 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT526874 | ERCC8 | ERCC excision repair 8, CSA ubiquitin ligase complex subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT530232 | WSB2 | WD repeat and SOCS box containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT532003 | ACTR2 | ARP2 actin related protein 2 homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT533371 | UBE2D4 | ubiquitin conjugating enzyme E2 D4 (putative) | ![]() |
![]() |
2 | 4 | ||||||
MIRT547106 | PIGW | phosphatidylinositol glycan anchor biosynthesis class W | ![]() |
![]() |
2 | 2 | ||||||
MIRT548189 | FOXA1 | forkhead box A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT552935 | VKORC1L1 | vitamin K epoxide reductase complex subunit 1 like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560085 | ZNF195 | zinc finger protein 195 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561726 | PPP2CA | protein phosphatase 2 catalytic subunit alpha | ![]() |
![]() |
2 | 2 | ||||||
MIRT562713 | ZNF415 | zinc finger protein 415 | ![]() |
![]() |
2 | 2 | ||||||
MIRT562761 | ZNF846 | zinc finger protein 846 | ![]() |
![]() |
2 | 2 | ||||||
MIRT564159 | ZNF117 | zinc finger protein 117 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565673 | SETD5 | SET domain containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT565718 | SESN3 | sestrin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566026 | RFX1 | regulatory factor X1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569048 | ZNF655 | zinc finger protein 655 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570367 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570410 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT570443 | TMEM189 | transmembrane protein 189 | ![]() |
![]() |
2 | 2 | ||||||
MIRT571738 | RNF11 | ring finger protein 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT575042 | Tpgs2 | tubulin polyglutamylase complex subunit 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT614330 | ZDHHC22 | zinc finger DHHC-type containing 22 | ![]() |
![]() |
2 | 2 | ||||||
MIRT617629 | RAB3IP | RAB3A interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT621667 | UBE4B | ubiquitination factor E4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT639906 | SRGAP2 | SLIT-ROBO Rho GTPase activating protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651436 | XRCC5 | X-ray repair cross complementing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT683853 | ZNF208 | zinc finger protein 208 | ![]() |
![]() |
2 | 2 | ||||||
MIRT684841 | TPGS2 | tubulin polyglutamylase complex subunit 2 | ![]() |
![]() |
2 | 5 | ||||||
MIRT689347 | ZNF83 | zinc finger protein 83 | ![]() |
![]() |
2 | 2 | ||||||
MIRT692492 | SPIN4 | spindlin family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT695711 | OLA1 | Obg like ATPase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT698219 | TMEM248 | transmembrane protein 248 | ![]() |
![]() |
2 | 2 | ||||||
MIRT711560 | FAM20B | FAM20B, glycosaminoglycan xylosylkinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT712867 | TMEM67 | transmembrane protein 67 | ![]() |
![]() |
2 | 2 | ||||||
MIRT722956 | TSPAN1 | tetraspanin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT723622 | SOBP | sine oculis binding protein homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT724176 | ABCF2 | ATP binding cassette subfamily F member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT755363 | LMBR1 | limb development membrane protein 1 | 3 | 1 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|